Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

You are viewing the site in preview mode

Skip to main content
Fig. 3 | Virology Journal

Fig. 3

From: Standardization, validation, and comparative evaluation of a convenient surrogate recombinant vesicular stomatitis virus plaque reduction test for quantification of Hantaan orthohantavirus (HTNV) neutralizing antibodies

Fig. 3

NAbs titer of serum sample from five HFRS bivalent inactive vaccine recipients at different time points post vaccination were measured by replication-competent rVSV-HTNV-GP based PRNT (left) or HTNV based FRNT (right). Y axis shows the percent of infection of each dilution point. Each line represent different time point. Error bars represent the SD

Back to article page

Virology Journal

ISSN: 1743-422X